Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Snapshots from the 2007 Gastrointestinal Cancers Symposium: Part I

Feb. 6, 2007

JNJ-26146900: novel selective androgen receptor modulator effective in rodent prostate cancer models

Feb. 5, 2007

SGX selects MET tyrosine kinase inhibitor development candidate

Feb. 5, 2007

NCI studies RM-1812 as chemopreventive agent

Feb. 5, 2007

Liposomal curcumin shows efficacy against head and neck cancer cells

Feb. 5, 2007

GX15-070 begins new trials in NSCLC and mantle cell lymphoma

Feb. 2, 2007

Systemic small molecule Hedgehog antagonist begins phase I testing

Feb. 2, 2007

Oral azacitidine cleared to begin phase I study

Feb. 2, 2007

DSMB stops phase III trial of tesmilifene in advanced breast cancer

Feb. 2, 2007

Australian organizations establish cooperative cancer research center

Feb. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...